Related Experiment Videos
Progress in epidermolysis bullosa: genetic classification and clinical implications
Jouni Uitto1, Gabriele Richard
1Department of Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, PA 19107, USA. Jouni.Uitto@jefferson.edu
Summary
Epidermolysis bullosa (EB) is a group of genetic skin disorders causing blistering. Identifying gene mutations explains EB
Area of Science:
- Dermatology
- Genetics
- Molecular Biology
Background:
- Epidermolysis bullosa (EB) is a group of genodermatoses characterized by skin fragility and blistering.
- EB presents with diverse clinical severity and extracutaneous manifestations.
- Subcategories are defined by clinical presentation and the level of tissue separation in the cutaneous basement membrane zone (BMZ).
Purpose of the Study:
- To delineate specific gene mutations in various EB forms.
- To correlate mutation types with phenotypic variability and genetic heterogeneity.
- To explore translational applications for diagnosis, classification, and genetic counseling in EB.
Main Methods:
- Clinical assessment of EB phenotypes.
- Genetic analysis to identify mutations in genes within the cutaneous BMZ.
- mRNA and protein level analysis to understand mutation consequences.
Main Results:
- Over 500 families with different EB variants have had specific mutations identified in ten distinct genes.
- Mutation types, positions, and consequences explain the wide spectrum of EB phenotypes.
- Tissue separation occurs at different levels, including hemidesmosomes in newer variants.
Conclusions:
- Understanding EB-associated gene mutations is crucial for explaining disease heterogeneity.
- Elucidation of mutations facilitates improved diagnosis, prognostication, and genetic counseling.
- Molecularly based classification and DNA-based prenatal testing are direct translational outcomes.